The bill amends 42 U.S.C. 293k(c)(1) to change the statutory authorization of funds for primary care training and enhancement grants and contracts. It replaces the existing authorized amount and years with a new line that provides $49,924,000 for each fiscal year 2025 through 2030.
The change is a narrow, program-specific reauthorization and a modest nominal increase of $1,000,000 per year compared with the prior authorization level. For organizations that rely on these federal grants—training programs, academic primary care centers, and community-based teaching sites—the bill aims to preserve funding continuity and give multi-year visibility, but it does not itself appropriate the funds or alter program priorities or distribution rules in the statute.
At a Glance
What It Does
The bill amends a single sentence in the Public Health Service Act (section 747(c)(1)), substituting a new funding figure and an updated set of fiscal years. The statutory authorization becomes $49,924,000 annually for fiscal years 2025 through 2030.
Who It Affects
Entities that receive or apply for primary care training and enhancement grants under section 747—medical schools, residency programs with primary care tracks, teaching health centers, and community health centers—could expect continued eligibility for program funds if Congress appropriates them. HHS (and its workforce offices like HRSA, which historically administer these grants) will remain the implementing agency.
Why It Matters
The amendment preserves a statutory funding stream and adds a small increase, giving program managers and grantees planning certainty if appropriations follow the authorization. It does not expand program scope, change funding formulas, or guarantee payment—so its practical effect depends on subsequent appropriation decisions.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
This bill performs one focused edit to the Public Health Service Act. It takes the sentence in 42 U.S.C. 293k(c)(1) that currently authorizes a specific dollar amount for a defined set of fiscal years and replaces that text with a new dollar figure and a new multi-year range.
The new statutory line calls for $49,924,000 per year and lists fiscal years 2025 through 2030 as the covered period.
Because the bill operates by changing the authorization language in statute, it leaves all other statutory mechanics of the program untouched: eligibility rules, grant purposes (primary care training and enhancement), and the authority for the Secretary of HHS to award grants and contracts remain as written elsewhere in the Public Health Service Act. In practice, HHS—through HRSA’s workforce offices—has administered these grants, so implementation would follow existing agency practice unless the agency issues different guidance.Two practical points matter for implementers.
First, authorization is not appropriation: this bill signals Congressional intent and sets a ceiling for possible funding, but actual outlays require appropriation language in an appropriations bill. Second, the amendment’s revised date range overlaps with the prior authorization (both include 2025 in the textual change), which can create administrative questions about which statutory line governs FY2025 depending on enactment timing and subsequent appropriations language.For grantees and program managers, the statute-level extension gives at least a form of predictability: Congress is authorizing the program through 2030 at a slightly higher annual level.
For budget and workforce planners, however, the increase is modest relative to broader primary care workforce shortages, and the bill does not tackle larger drivers—such as residency slot funding, Medicare GME policy, or targeted incentives—that affect the number of practicing primary care physicians over the long term.
The Five Things You Need to Know
The bill amends 42 U.S.C. 293k(c)(1) — the statutory authorization for primary care training and enhancement grants.
It replaces the prior authorization of $48,924,000 per year (fiscal years 2021–2025) with $49,924,000 per year (fiscal years 2025–2030).
The nominal increase is $1,000,000 annually compared with the previous authorized level.
The change is an authorization of appropriations; it does not appropriate funds or alter eligibility, priorities, or program structure in the underlying statutory sections.
The revised fiscal-year range (2025–2030) extends the program’s statutory authorization for six years, which could affect multi-year planning if appropriations follow.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Gives the Act the name 'Train More Primary Care Doctors Act of 2025.' This is purely nominal and does not change any program mechanics; expect the short title to appear in citations and legislative history.
Amendment to Public Health Service Act (section 747(c)(1))
Performs a textual substitution in 42 U.S.C. 293k(c)(1): it strikes the clause that authorized $48,924,000 for fiscal years 2021 through 2025 and inserts a clause authorizing $49,924,000 for fiscal years 2025 through 2030. Mechanically, this is a single-line statutory edit that changes only the authorized dollar amount and the range of fiscal years; it does not modify grant authorities, selection criteria, or program definitions that appear elsewhere in the statute.
Authorization vs. appropriation and implementation notes
While the statute will show an updated authorization level and time span, the bill contains no language that obligates funds. Implementation depends on future appropriations and any accompanying committee report language or appropriations riders. Agencies that already administer this program will follow existing grant procedures unless HHS issues new program guidance or Congress specifies different uses in appropriations law.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Existing primary care training grantees — medical schools, residency programs, and training consortia that currently receive awards will gain continuity of statutory authorization which supports multi-year planning if appropriations follow.
- Community-based teaching sites and teaching health centers — these sites often rely on Section 747 funds to host trainees and may retain grant eligibility through the extended authorization window.
- State and regional workforce offices — greater statutory predictability can help state workforce planners coordinate federal grants with state initiatives to expand primary care pipelines.
Who Bears the Cost
- Congressional appropriations — any real cost depends on future appropriations committees choosing to fund the authorized amounts, potentially displacing other priorities within discretionary health workforce budgets.
- HHS/HRSA administrative operations — administering multi-year grants requires staffing and oversight resources; if Congress appropriates new money, the agency must allocate administrative resources to manage expanded or continuing awards.
- Other federal health workforce programs — in a capped discretionary environment, directing funds to this program may limit funding available for other workforce strategies (e.g., GME expansion, loan repayment programs) absent additional appropriations.
Key Issues
The Core Tension
The central dilemma is between incremental statutory sustainment and structural reform: the bill renews and slightly increases authorization for an existing training grant program to preserve short-term continuity, but it does not tackle larger, costlier drivers of primary care supply (like expanding residency positions), so it buys predictability without resolving whether the scale is sufficient to meet long-term workforce needs.
The bill’s changes are narrowly drafted but leave open several implementation questions. First, authorization language provides no automatic funding; the program’s practical impact hinges on subsequent appropriations.
Agencies and grantees may read the reauthorization as a signal, but that signal only becomes money if appropriators act. Second, the numerical increase is modest relative to the scale of primary care shortages and does not address major structural levers such as Medicare GME slots, which drive the supply of residency positions and thus the physician pipeline.
Third, the amendment replaces a date range that included 2025 with a new range that also begins in 2025; depending on enactment timing and appropriations text, there could be ambiguity about which statutory figure governs FY2025, creating brief administrative or accounting questions for HHS and Treasury.
Additionally, the bill leaves untouched the statute’s distribution mechanisms and eligibility rules, so existing inequities in how grants are awarded (geographic concentration, institutional capacity differences) will persist unless agency rulemaking or appropriations riders change program priorities. From a budgeting and oversight perspective, the modest one‑time line-item increase is unlikely to attract significant CBO savings or costs, but it will be counted against discretionary caps if appropriated—forcing trade-offs within health workforce funding lines.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.